We set an agenda for a psychedelic science of spirituality and religion, based on a synthesis of attachment theory with the Relaxed Beliefs Under pSychedelics (REBUS) model.

The majority of US addiction specialists, including psychiatrists, believe psychedelics are promising for the treatment of substance use disorders.

Understanding the mechanisms of action and evaluating their synergistic efficacy in scientific studies will be critical to advance the framework of psychedelic-assisted therapy for addiction.

We review data related to expectation and placebo effects, but argue that claims that microdosing effects are largely due to expectancy are premature and possibly wrong.

The present study provides a systematic and in-depth analysis of the nuanced content of the otherworldly encounter within the breakthrough DMT experience.

Focusing on the Research Domain Criteria (RDoC) as a template, we will describe the multimodal mechanisms underlying the transdiagnostic therapeutic effects of psychedelic therapy

Abusing psychoactive substances has been a popular sport in the business world since the mid-19th century.

Psychedelics are uniquely capable of reliably occasioning mystical experiences in ordinary humans without contemplative or religious backgrounds.

This model expands ACT by integrating practises and data from psychedelic-assisted therapy research.

NHS psychiatrists are positive about the potential for psychedelic-assisted therapy to advance psychiatric practise.

A suitability test may be a useful tool when determining whether a prescription of psilocybin is an appropriate course of treatment.

This analytic approach might suggest unique applications for psychedelic-assisted treatments and provide perspectives on phenomena outside the field.

Use of psychedelics in the collective rituals of numerous indigenous groups suggests that these substances are powerful catalysts of belief transmission.

The current study examined the correlations between psychedelic treatment (ibogaine & 5-MeO-DMT) and changes in alcohol misuse among trauma exposed United States SOFV.

This is the first NIH grant awarded in over a half century to directly investigate the therapeutic effects of a classic psychedelic

Our results indicate health and wellness motives and perceived mental health benefits among microdosers

Individualized dose escalation of 5-MeO-DMT may be preferable over single dose administration for clinical applications that aim to elicit a strong therapeutic response.

Our findings hold implications for the potential use of psychedelics for treating interpersonal elements of personality pathology as well as loneliness.

A model to support MDMA-assisted couple therapy is introduced, and future directions, including implications for intervention development and delivery, will be elucidated."

This review aims to discuss how psychedelics can promote and intensify psychotherapeutic key processes.